ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SUN Surgical Innovations Group Plc

0.50
-0.05 (-9.09%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Surgical Innovations Group Plc LSE:SUN London Ordinary Share GB0004016704 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  -0.05 -9.09% 0.50 1,634,113 08:45:42
Bid Price Offer Price High Price Low Price Open Price
0.40 0.60 0.55 0.50 0.55
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Surgical,med Instr,apparatus 11.34M 264k 0.0003 16.67 4.66M
Last Trade Time Trade Type Trade Size Trade Price Currency
16:31:08 O 200,000 0.49 GBX

Surgical Innovations (SUN) Latest News

Surgical Innovations (SUN) Discussions and Chat

Surgical Innovations (SUN) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2024-03-28 16:31:090.49200,000980.00O
2024-03-28 16:14:280.492000.98O
2024-03-28 14:35:180.4915,46375.00O
2024-03-28 13:11:180.442,0008.70O
2024-03-28 12:14:150.4449,500215.37O

Surgical Innovations (SUN) Top Chat Posts

Top Posts
Posted at 29/3/2024 08:20 by Surgical Innovations Daily Update
Surgical Innovations Group Plc is listed in the Surgical,med Instr,apparatus sector of the London Stock Exchange with ticker SUN. The last closing price for Surgical Innovations was 0.55p.
Surgical Innovations currently has 932,816,000 shares in issue. The market capitalisation of Surgical Innovations is £4,664,080.
Surgical Innovations has a price to earnings ratio (PE ratio) of 16.67.
This morning SUN shares opened at 0.55p
Posted at 19/3/2024 21:45 by z1co
cashflo

Just ignore PUGUGLY ,the idiot thinks he's clever.That's the 2nd of my stocks he's deramped in the last 4 weeks , he first tried to deramp PIP and now SUN.

Z1CO is on his case , no one likes to have a monkey on their back.
Posted at 04/3/2024 17:45 by z1co
Hi cashflo

Holding some shares is very boring , it looks like SUN falls in this category.

I'm very optimistic that when they announce results this month the outlook for 2024 will be much better than last year and this will put some life back in to these dead shares.
Posted at 28/2/2024 18:24 by cashflo
Not much in the way of innovation regarding the share price here is there folks?
Posted at 24/2/2024 09:20 by z1co
cashflo

Since the trading update on the 29/01/2024 there has been a total buys of apprx 16m shares and most have been bought below the mid price suggesting MM's have a lot of shares on their hands.

Taking in to account the continues decline of the share price last year from over 2p to 0.6p , there must have been a lot selling over the period.

Once MM's offload these excess shares the price will hopefully begin to rise in 2024 due to the business trading far stronger than 2023.

All the recent trades of 0.625p and above have been buys.

Coming back to your comments regarding trades on 22/02/2024:

There were 650,000 buys 201,000 sells and the last 4 trades of 250,000 were most likely sold and bought back in ISA ie like a rollover.
Posted at 17/2/2024 09:49 by z1co
Share price ticked up a wee bit after their trading update on 29/01/2024.

Last year they announced their full year results on 29/03/2023 , not long to go.
Posted at 17/2/2024 08:33 by z1co
Despite all the supply chain challenges and the industrial actions in the NHS the company experienced in 2023 they still managed to achieve a record sales of £12m which was slightly ahead of expectations.

The company has started the current year with an encouraging order book and the recent actions taken to improve operational efficiencies including the re-introduction of a 5-day working week is on track to deliver further improvements to the gross margin in 2024.

The company will update the market next month when they announce their full year results, which will show a marked improvement in trading over the previous year.

Share price which is still at the lows and will start to rise as the year progresses.
Posted at 02/2/2024 12:30 by z1co
The trading update was definitely better than expectations as is the outlook for 2024 but the price has not risen further due to too many shares in the hands of MM's hence you can still buy at below mid at 0.675p.

Once the overhang is cleared the share price will start to rise higher.
Posted at 29/1/2024 14:29 by z1co
Hold them until at least the results , shares will rise.The fall was over done on uncertainty.The company has traded marginally ahead of expectations in H2.

Sales in H2 were 13% higher than the first 6 months.

Outlook for 2024 is also upbeat.

David Marsh, CEO of Surgical Innovations Group Plc, said: "Despite a challenging 2023, the Company finished the year with record sales and entered 2024 with an encouraging order book".

The share price at 0.6p was even lower than 2020 during the covid-19 period.

Was way over sold.
Posted at 29/1/2024 08:15 by z1co
Year-end 2023 Trading Update



Record sales and operational efficiency programme on track



Surgical Innovations Group Plc (AIM: SUN), the designer, manufacturer and distributor of innovative technology for minimally invasive surgery, provides an update on trading for the year ended 31 December 2023, with sales marginally head of market expectations.



Unaudited Financials

Revenues for the year are expected to be approximately £12.0m, an increase of 6% compared with the prior year (2022: £11.3m). Group revenues continued to grow in H2 in line with the Board's expectations, with key markets and OEM sales in particular performing strongly. Sales for the second half of the year were approximately 13% higher than the first half. The Group expects to report a positive adjusted EBITDA1 of £0.2m, in-line with expectations. Operational improvements continue to be implemented in the new financial year and are expected to enhance future profitability.



The closing net cash2 balances of the Group stood at approximately £0.36m at 31 December 2023 (30 June 2023: £0.38m), with available gross cash resources at 31 December 2023 of £2.21m (30 June 2023: £2.41m) including an undrawn invoice discounting facility of £1.0m (30 June 2023: £1.0m).



UK sales remained strong in H2 2023, driven by the resonance of the sustainability messaging for both the NHS and Private Healthcare providers. Growing global acceptance of the need to adopt more sustainable solutions in healthcare is also driving growth in key markets in Europe, APAC and ROW. Despite supply chain challenges in H2 2023, the OEM business produced strong sales and carried a positive order book into 2024.



The recently implemented operating efficiency programme, which includes the re-introduction of a 5-day working week, is on track to deliver further improvements to the gross margin in 2024.



Current trading and outlook

While continued industrial action in the NHS has impacted the volume of elective surgeries and slowed some of the progress with evaluations, it is not anticipated to affect Q1 sales. Across the Company's distribution network, expected sales remain on track to deliver management forecasts. Some of the supply chain issues seen last year have impacted OEM sales, but these are now resolved and are not expected to have a material bearing on Q1 performance.



David Marsh, CEO of Surgical Innovations Group Plc, said: "Despite a challenging 2023, the Company finished the year with record sales and entered 2024 with an encouraging order book. The recent actions taken to improve operational efficiencies, together with continued increasing sales momentum, give the Board confidence that we have put the business onto a sustainable growth trajectory for 2024 and beyond."
Posted at 29/1/2024 08:14 by z1co
!FOLLOWFEED
Year-end 2023 Trading Update:

Record sales and operational efficiency programme on track

Surgical Innovations Group Plc (AIM: SUN), the designer, manufacturer and distributor of innovative technology for minimally invasive surgery, provides an update on trading for the year ended 31 December 2023, with sales marginally head of market expectations.
Surgical Innovations share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock